Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Sanofi ADR

SNW
Current price
93.42 EUR -1.71 EUR (-1.81%)
Last closed 48.61 USD
ISIN US80105N1054
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Frankfurt Exchange
Capitalization 119 617 560 576 USD
Yield for 12 month -6.03 %
1Y
3Y
5Y
10Y
15Y
SNW
21.11.2021 - 28.11.2021

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France. Address: 46, avenue de la Grande Armée,, Paris, France, 75017

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

63.06 USD

P/E ratio

25.24

Dividend Yield

4.20 %

Current Year

+47 848 217 840 USD

Last Year

+47 178 823 008 USD

Current Quarter

+14 715 252 535 USD

Last Quarter

+11 828 747 182 USD

Current Year

+33 050 850 100 USD

Last Year

+32 946 906 803 USD

Current Quarter

+10 469 168 859 USD

Last Quarter

+8 304 029 986 USD

Key Figures SNW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 12 502 500 352 USD
Operating Margin TTM 28.81 %
PE Ratio 25.24
Return On Assets TTM 4.16 %
PEG Ratio 0.83
Return On Equity TTM 5.82 %
Wall Street Target Price 63.06 USD
Revenue TTM 48 445 001 728 USD
Book Value 58.10 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 11.50 %
Dividend Yield 4.20 %
Gross Profit TTM 31 697 000 000 USD
Earnings per share 1.89 USD
Diluted Eps TTM 1.89 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 11.50 %
Profit Margin 9.30 %

Dividend Analytics SNW

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

4.93 %

5Y Dividend Growth

17.00 %

Consecutive Years

2 years

5Y Average Payout Ratio

51.00 %

Dividend History SNW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 2.04
Ex Dividend Date 09.05.2024
Forward Annual Dividend Yield 4.27 %
Last Split Factor 5:1
Payout Ratio 46.72 %
Last Split Date 30.09.2013
Dividend Date 06.06.2024

Stock Valuation SNW

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 25.24
Forward PE 10.53
Enterprise Value Revenue 2.69
Price Sales TTM 2.47
Enterprise Value EBITDA 14.50
Price Book MRQ 1.57

Financials SNW

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SNW

For 52 weeks

45.22 USD 58.97 USD
50 Day MA 50.39 USD
Shares Short Prior Month 8 830 272
200 Day MA 50.92 USD
Short Ratio 2.00
Shares Short 4 532 070
Short Percent 0.20 %